Recent Quotes (30 days)

You have no recent quotes
chg | %

Annidis Corporation  

(Public, CVE:RHA)   Watch this stock  
Find more results for RHA
0.000 (0.00%)
Apr 9 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.16 - 0.80
Open     -
Vol / Avg. 0.00/8,721.00
Mkt cap 19.17M
P/E     -
Div/yield     -
EPS -0.06
Shares 95.87M
Beta -1.40
Inst. own     -

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -258.41% -403.88%
Operating margin -211.33% -319.56%
EBITD margin - -298.91%
Return on average assets -183.95% -155.88%
Return on average equity - -
CDP Score - -


100 Maple Grove Rd
+1-519-6721524 (Phone)
+1-519-6726950 (Fax)

Website links


Annidis Corporation is a Canada-based eye-care solutions company. The Company�s product aims to improve healthcare through eye-centric products and services that help eye care professionals screen, detect, diagnose, treat and manage ocular diseases. The Company partners with ocular science institutions including the University of Ottawa Eye Institute, The Ottawa Health Research Institute and the University of Montreal, School of Optometry. The Company�s RHA is an integrated system with two components: RHA Instrument and RHA Report. The RHA instrument is a multi-spectral imaging digital ophthalmoscope with an optical system that captures image data through the retinal and subretinal layers enabling eye care professionals use to distinguish between ocular structures. The RHA Report is a data analysis and reporting software package that processes and analyzes the RHA image data sets, creating a program for professional assessment and diagnosis of the patient�s ocular and general health.

Officers and directors

Michael P. Mueller Chairman of the Board
Zeljko Ribaric President, Director
Gerald Slemko Chief Executive Officer, Director
Age: 59
Brian Baker Chief Financial Officer
Michael Francis Crowley Independent Director
Robert G. Devenyi Independent Director
Rony Thomas Independent Director